New Investigational Targeted Therapy Shows Early Promise in Patients With Solid Tumors
Second-generation PRMT5 inhibitor targets synthetic lethality in several cancer types with MTAP loss BOSTON – AMG 193, a second-generation...
Search/Filter
Loading...
NCI-sponsored Cancer Clinical Trials Have Become More Diverse Over Past Two Decades
ORLANDO, Fla. – Compared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022...
Structural Racism May Play a Role in Increased Cancer Mortality Rates Among Racial Minorities
ORLANDO, Fla. – Structural racism was associated with increased county-level cancer mortality rates among minority populations compared with whites,...
Racial and Ethnic Minorities May Be Less Willing Than Others to Participate in Clinical Trials
Survey found that most people are open to participating, and motivation varied by racial and ethnic group ORLANDO, Fla....
Spanish-speaking Men in Sexual Minority Groups May Lack Knowledge About Cancers Linked to HPV
Most men in survey were never offered the HPV vaccine ORLANDO, Fla. – A study found multiple gaps in...
Racial/Ethnic Minority Patients May Be Less Likely Than White Patients to Receive Palliative Care During Breast Cancer Treatment
Palliative care use increased among all racial/ethnic groups from 2004 to 2020 ORLANDO, Fla. – Despite a steady increase...
Brain Metastases in Patients with Kidney Cancer May Have Immune-suppressive Tumor Microenvironments
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets in brain metastases ORLANDO, Fla. –...
Olaparib Plus Ceralasertib May Benefit Pediatric Cancer Patients With DNA Repair-deficient Tumors
ORLANDO, Fla. – A combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clinical...
An Investigational Deep Learning Model May Help Stratify Risk for Patients with Endometrial Cancer
ORLANDO, Fla. – An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence...
Exome Sequencing Identifies Individuals With Cancer Predisposition Syndromes Missed by Current Screening Guidelines
ORLANDO, Fla. – Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for...